Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 21 04:00PM ET
10.25
Dollar change
+0.01
Percentage change
0.05
%
Index- P/E- EPS (ttm)-1.02 Insider Own25.59% Shs Outstand95.93M Perf Week-0.87%
Market Cap983.28M Forward P/E- EPS next Y-0.19 Insider Trans0.00% Shs Float71.38M Perf Month2.30%
Income-70.80M PEG- EPS next Q-0.04 Inst Own40.39% Short Float1.66% Perf Quarter107.49%
Sales0.00M P/S- EPS this Y20.61% Inst Trans-3.18% Short Ratio0.87 Perf Half Y222.33%
Book/sh2.31 P/B4.43 EPS next Y6.84% ROA-27.34% Short Interest1.19M Perf Year369.11%
Cash/sh2.44 P/C4.21 EPS next 5Y- ROE-32.38% 52W Range1.40 - 10.44 Perf YTD2.09%
Dividend Est.- P/FCF- EPS past 5Y-68.83% ROI-31.22% 52W High-1.77% Beta-0.35
Dividend TTM- Quick Ratio7.73 Sales past 5Y-25.00% Gross Margin- 52W Low632.14% ATR (14)0.16
Dividend Ex-Date- Current Ratio7.73 EPS Y/Y TTM25.45% Oper. Margin0.00% RSI (14)68.18 Volatility1.12% 1.27%
Employees314 Debt/Eq0.07 Sales Y/Y TTM-100.00% Profit Margin- Recom2.11 Target Price10.58
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q70.00% Payout- Rel Volume4.71 Prev Close10.24
Sales Surprise- EPS Surprise60.16% Sales Q/Q- EarningsNov 13 BMO Avg Volume1.36M Price10.25
SMA200.50% SMA5013.54% SMA200106.21% Trades Volume6,416,915 Change0.05%
Date Action Analyst Rating Change Price Target Change
Nov-27-23Initiated Evercore ISI Outperform
Oct-19-23Initiated Stifel Buy $11
Mar-27-23Resumed Wells Fargo Overweight $7
Dec-08-22Initiated H.C. Wainwright Buy $6
Sep-22-22Initiated Citigroup Buy $12
Aug-18-22Resumed Wells Fargo Overweight
Jun-01-22Initiated Cantor Fitzgerald Overweight $20
Apr-04-22Initiated BTIG Research Buy $18
Feb-03-21Initiated Citigroup Buy $35
Feb-02-21Initiated Wells Fargo Overweight $33
Feb-20-24 07:45AM
Jan-29-24 07:00AM
Jan-08-24 10:06AM
Jan-03-24 12:00PM
Dec-27-23 11:02AM
04:35PM Loading…
Dec-26-23 04:35PM
04:26PM
01:03PM
12:52PM
09:44AM
08:46AM
07:51AM
07:20AM
03:26AM
02:43AM
02:09AM Loading…
02:09AM
02:01AM
02:00AM
Dec-21-23 08:50AM
07:00AM
Dec-11-23 07:30PM
09:55AM
Nov-27-23 08:00AM
Nov-23-23 12:00PM
09:55AM
Nov-16-23 08:00AM
Nov-14-23 01:03AM
Nov-13-23 07:30AM
Nov-09-23 08:36AM
Nov-08-23 08:30AM
09:00AM Loading…
Nov-02-23 09:00AM
Nov-01-23 04:00PM
Oct-31-23 09:00AM
Oct-30-23 02:02PM
09:32AM
08:30AM
Sep-27-23 08:30AM
Sep-26-23 04:00PM
Sep-19-23 09:21AM
Sep-14-23 09:15AM
Sep-12-23 09:55AM
Sep-06-23 08:00AM
Aug-24-23 04:10PM
Aug-21-23 09:02PM
Aug-15-23 12:51AM
Aug-14-23 07:15AM
Aug-07-23 02:12PM
07:45AM
Jul-31-23 04:02PM
09:00AM
Jun-20-23 08:30AM
Jun-14-23 11:45AM
Jun-13-23 03:29PM
Jun-10-23 10:30AM
Jun-03-23 02:15PM
May-24-23 04:01PM
May-16-23 12:12AM
May-15-23 09:15AM
07:00AM
07:00AM
May-11-23 04:00PM
May-10-23 04:19PM
May-02-23 04:00PM
Apr-26-23 10:15AM
Apr-25-23 04:13PM
Mar-22-23 04:10PM
Mar-14-23 12:27AM
Mar-13-23 07:30AM
Feb-28-23 08:00AM
Feb-27-23 08:00AM
Feb-26-23 09:10AM
Feb-14-23 08:46AM
Feb-13-23 07:30AM
Feb-03-23 07:30AM
Jan-16-23 06:23AM
Dec-12-22 10:39AM
Dec-10-22 06:15PM
Dec-08-22 01:28PM
Nov-23-22 08:00AM
Nov-16-22 08:00AM
Nov-14-22 07:15AM
Nov-03-22 09:10AM
Oct-31-22 09:00AM
Oct-24-22 09:00AM
Oct-17-22 08:05AM
Sep-14-22 08:30AM
Aug-29-22 09:00AM
Aug-15-22 07:15AM
Aug-08-22 09:46AM
Aug-02-22 09:00AM
Aug-01-22 08:00AM
Jul-26-22 08:30AM
Jul-19-22 08:00AM
Jun-14-22 08:00AM
Jun-13-22 10:12AM
Jun-12-22 08:00AM
Jun-03-22 11:00AM
May-26-22 05:01PM
May-19-22 08:30AM
May-16-22 07:30AM
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.